Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
Many individuals with schizophrenia smoke cigarettes but little is known about the factors
that control smoking in people with schizophrenia. The purpose of this trial is to evaluate
how bupropion, an antidepressant medication, affects smoking behaviors in individuals with
schizophrenia who smoke.